The UK is committed to rapid equitable access to safe and effective vaccines, and is playing a leading role in financing the global effort, and identifying solutions that ensure affordable access for all.<\/p>
The UK Government does not consider waiving intellectual property (IP) rights to be an appropriate course of action in boosting the manufacturing of safe, effective, and quality vaccines. The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies to detect, treat, and defend against COVID-19. The incentives and access mechanisms provided by the IP framework have been integral to this success, without which we would not have seen the impressive surge of research and development, and the unprecedented scaling up of production.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"} } , "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"} , "answeringMemberPrinted" : {"_value" : "Wendy Morton"} , "dateOfAnswer" : {"_value" : "2021-02-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-15T09:33:49.997Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2021-02-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment the Government has made of the effect on global equality of access to the covid-19 vaccines in the event that the proposed WTO TRIPS Waiver is not adopted.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4500", "label" : {"_value" : "Biography information for Clive Lewis"} } , "tablingMemberConstituency" : {"_value" : "Norwich South"} , "tablingMemberPrinted" : [{"_value" : "Clive Lewis"} ], "uin" : "149801"} , {"_about" : "http://data.parliament.uk/resources/1284400", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1284400/answer", "answerText" : {"_value" : "
The UK will champion rapid equitable access to safe and effective vaccines throughout our G7 Presidency.<\/p>
Since the World Health Organisation (WHO) provided initial details on the COVID-19 technology access pool (C-TAP) in October, the UK has led the way in bringing industry and the research community to the table. During our G7 presidency, we will continue this work with stakeholders and the WHO as it establishes the governance structures and refines the operating model for C-TAP.<\/p>
The FCDO is working closely with key development partners in vaccines, such as the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccines Alliance, WHO and the United Nations International Children's Emergency Fund (UNICEF), along with development finance institutions and the private sector to catalyse investments for vaccine manufacturing in Africa.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"} } , "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"} , "answeringMemberPrinted" : {"_value" : "Wendy Morton"} , "dateOfAnswer" : {"_value" : "2021-02-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-12T11:48:39.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2021-02-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if the Government will take steps to use its Presidency of the G7 to propose support for (a) the WHO COVID-19 Technology Access Pool and (b) increasing Official Development Assistance funding to scale-up vaccine manufacturing capacity in low and middle income countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4500", "label" : {"_value" : "Biography information for Clive Lewis"} } , "tablingMemberConstituency" : {"_value" : "Norwich South"} , "tablingMemberPrinted" : [{"_value" : "Clive Lewis"} ], "uin" : "149803"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }